diosgenin has been researched along with Multiple Myeloma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, B; Chen, P; Dong, X; Wu, S; Xu, P; Zhou, M | 1 |
| He, X; Jin, XL; Li, X; Liang, Y; Qiu, X; Xu, RZ; Zhao, XY | 1 |
2 other study(ies) available for diosgenin and Multiple Myeloma
| Article | Year |
|---|---|
Formosanin C induces autophagy-mediated apoptosis in multiple myeloma cells through the PI3K/AKT/mTOR signaling pathway.
Topics: Apoptosis; Apoptosis Regulatory Proteins; Autophagy; Autophagy-Related Proteins; Cell Line, Tumor; Diosgenin; Humans; Multiple Myeloma; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Saponins; Signal Transduction; TOR Serine-Threonine Kinases | 2022 |
Polyphyllin I induces cell cycle arrest and apoptosis in human myeloma cells via modulating β-catenin signaling pathway.
Topics: Apoptosis; beta Catenin; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Survival; Diosgenin; Gene Expression; Humans; Multiple Myeloma; Proton Pump Inhibitors; RNA, Messenger; Signal Transduction | 2016 |